Form 4: Amgen EVP David M. Reese Reports Stock Disposal for Tax Obligations
SEC Form 4 Filing
David M. Reese, EVP & Chief Technology Officer of Amgen, disposed of 633 shares of common stock on May 5, 2024, to cover tax obligations.
Summary
- On May 5, 2024, David M. Reese, the EVP & Chief Technology Officer of Amgen Inc., disposed of 633 shares of Amgen's common stock.
- The transaction was executed at a price of $311.29 per share.
- This disposal was related to covering tax obligations.
- Following the transaction, Reese beneficially owns 58,693 shares of Amgen common stock.
- These shares include Restricted Stock Units (RSUs) vesting at various dates in the future and Dividend Equivalents (DEs).
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing related to stock transactions for tax purposes, indicating a neutral sentiment.
Industry Context
Form 4 filings are a routine part of executive compensation and provide transparency into insider transactions. This transaction is a common occurrence where executives sell shares to cover tax obligations related to vesting equity.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a routine sale by an executive to cover tax obligations.
Key Dates
| Date | Description |
|---|---|
| 05/05/2024 | Date of stock disposal transaction. |
| 05/06/2024 | Date of signature on the Form 4 filing. |
| 4/30/2025 | Vesting date for 1,363 RSUs. |
| 5/2/2025 | Vesting date for 1,286 RSUs. |
| 5/2/2026 | Vesting date for 1,325 RSUs. |
| 5/2/2027 | Vesting date for 1,297 RSUs. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.